(HealthDay)—Budesonide oral suspension (BOS) is associated with improvement in symptomatic, endoscopic, and histologic parameters in adolescent and young adult patients with eosinophilic esophagitis (EoE), according to ...
Mar 28, 2017
0
111
The good news: a monoclonal antibody treatment called benralizumab proved quite effective in a clinical trial at depleting the number of eosinophils found in the blood and digestive tract tissues of patients with eosinophilic ...
Jun 16, 2023
0
112
A weekly dose of dupilumab, a monoclonal antibody, led to a reduction of symptoms and tissue improvement in young adults and adolescents with eosinophilic esophagitis (EoE), according to a new study published in the New England ...
Dec 22, 2022
0
25
(HealthDay)—For children with eosinophilic esophagitis (EoE), eight weeks of a four-food elimination diet can induce remission, according to a study published online June 8 in Clinical Gastroenterology and Hepatology.
Jul 7, 2017
0
1
Inspired by kirigami, the Japanese art of folding and cutting paper to create three-dimensional structures, MIT engineers and their collaborators have designed a new type of stent that could be used to deliver drugs to the ...
Jun 14, 2021
0
13
A new study from Ann & Robert H. Lurie Children's Hospital of Chicago determined the threshold for a new measure of early scarring in the esophagus of children with eosinophilic esophagitis (EoE), which allows immediate intervention ...
Sep 16, 2022
0
34
Personalized medicine—where the proper medicine and proper dose are used for the individual patient—moved a step closer to reality for children suffering from eosinophilic esophagitis (EoE), an inflammation of the food ...
Sep 12, 2019
0
3
A review of studies about the effect of food insecurity on digestive diseases found a dearth of information, even as diet can often be both a direct cause of and a solution for many gastrointestinal conditions.
Jun 2, 2022
0
28
University of Utah engineers mapped white blood cells called eonsinophils and showed an existing diagnostic method may overlook an elusive digestive disorder that causes swelling in the esophagus and painful swallowing.
Sep 6, 2012
0
0
EnteroTrack, LLC and the University of Colorado (CU) have executed an exclusive license agreement that will allow the company to develop and market a novel device to monitor inflammation of the gastrointestinal tract.
Jan 6, 2015
0
6
